Effects of arsenic exposure on DNA methylation and epigenetic gene regulation
- PMID: 20514360
- PMCID: PMC2877392
- DOI: 10.2217/epi.09.45
Effects of arsenic exposure on DNA methylation and epigenetic gene regulation
Abstract
Arsenic is a nonmutagenic human carcinogen that induces tumors through unknown mechanisms. A growing body of evidence suggests that its carcinogenicity results from epigenetic changes, particularly in DNA methylation. Changes in gene methylation status, mediated by arsenic, have been proposed to activate oncogene expression or silence tumor suppressor genes, leading to long-term changes in the activity of genes controlling cell transformation. Mostly descriptive, and often contradictory, studies have demonstrated that arsenic exposure is associated with both hypo- and hyper-methylation at various genetic loci in vivo or in vitro. This ambiguity has made it difficult to assess whether the changes induced by arsenic are causally involved in the transformation process or are simply a reflection of the altered physiology of rapidly dividing cancer cells. Here, we discuss the evidence supporting changes in DNA methylation as a cause of arsenic carcinogenesis and highlight the strengths and limitations of these studies, as well as areas where consistencies and inconsistencies exist.
Keywords: DNMT; S-adenosylmethionine; SAM; arsenate; arsenic; arsenite; cancer; carcinogenesis; epigenetics; glutathione; hypermethylation; hypomethylation; oxidative stress; transsulfuration.
Figures


Similar articles
-
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].Nihon Eiseigaku Zasshi. 2015;70(3):181-5. doi: 10.1265/jjh.70.181. Nihon Eiseigaku Zasshi. 2015. PMID: 26411935 Review. Japanese.
-
Transplacental arsenic exposure produced 5-methylcytosine methylation changes and aberrant microRNA expressions in livers of male fetal mice.Toxicology. 2020 Apr 15;435:152409. doi: 10.1016/j.tox.2020.152409. Epub 2020 Feb 14. Toxicology. 2020. PMID: 32068019 Free PMC article.
-
Analysis of the dynamic aberrant landscape of DNA methylation and gene expression during arsenic-induced cell transformation.Gene. 2019 Aug 30;711:143941. doi: 10.1016/j.gene.2019.143941. Epub 2019 Jun 23. Gene. 2019. PMID: 31242453
-
An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.Environ Health Perspect. 2011 Jan;119(1):11-9. doi: 10.1289/ehp.1002114. Epub 2010 Aug 2. Environ Health Perspect. 2011. PMID: 20682481 Free PMC article. Review.
-
Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes.Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10. Toxicol Sci. 2015. PMID: 25304211 Free PMC article.
Cited by
-
Quantitative Mass Spectrometry Reveals Changes in Histone H2B Variants as Cells Undergo Inorganic Arsenic-Mediated Cellular Transformation.Mol Cell Proteomics. 2016 Jul;15(7):2411-22. doi: 10.1074/mcp.M116.058412. Epub 2016 May 11. Mol Cell Proteomics. 2016. PMID: 27169413 Free PMC article.
-
Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.Metab Brain Dis. 2015 Jun;30(3):645-58. doi: 10.1007/s11011-014-9642-0. Epub 2015 Jan 15. Metab Brain Dis. 2015. PMID: 25588751 Review.
-
Does arsenic increase the risk of neural tube defects among a highly exposed population? A new case-control study in Bangladesh.Birth Defects Res. 2017 Jan 30;109(2):92-98. doi: 10.1002/bdra.23577. Birth Defects Res. 2017. PMID: 27801974 Free PMC article.
-
The epigenome as a potential mediator of cancer and disease prevention in prenatal development.Nutr Rev. 2013 Jul;71(7):441-57. doi: 10.1111/nure.12030. Epub 2013 May 15. Nutr Rev. 2013. PMID: 23815143 Free PMC article. Review.
-
Gender difference in arsenic biotransformation is an important metabolic basis for arsenic toxicity.BMC Pharmacol Toxicol. 2022 Feb 28;23(1):15. doi: 10.1186/s40360-022-00554-w. BMC Pharmacol Toxicol. 2022. PMID: 35227329 Free PMC article.
References
Bibliography
-
- Chen CJ, Kuo TL, Wu MM. Arsenic and cancers. Lancet. 1988;1(8582):414–415. - PubMed
-
- Hopenhayn-Rich C, Biggs ML, Fuchs A, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996;7(2):117–124. - PubMed
-
- Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl Cancer Inst. 2007;99(12):920–928. - PubMed
■ Websites
-
- IARC . Some Drinking-Water Disinfectants and Contaminants, Including Arsenic. Vol. 84. Who Press; Geneva, Switzerland: 2004. IARC Monographs on the Evaluation of Carcinogenic Risks to Human IARC Monographs. ISBN-13 9789283212843, ISBN-10 9283212843. http://monographs.iarc.fr/ENG/Monographs/vol84/index.php. - PMC - PubMed
-
- ATSDR . Toxicological Profile for Arsenic. Department of Health and Human Services, Public Health Service; GA, USA: 2007. Toxicological profile for Arsenic. www.atsdr.cdc.gov/toxprofiles/tp2.html.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical